CareDx (CDNA) Net Income towards Common Stockholders (2013 - 2026)

CareDx (CDNA) has 14 years of Net Income towards Common Stockholders data on file, last reported at $2.8 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 127.13% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.2 million (down 113.2% YoY) and the FY2025 annual result came in at -$21.4 million, down 140.64% from the prior year.
• Net Income towards Common Stockholders improved to $2.8 million in Q1 2026 per CDNA's latest filing, from -$4.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $87.7 million in Q4 2024, with the low at -$118.1 million in Q4 2023.
• Average Net Income towards Common Stockholders over 5 years is -$13.7 million, with a median of -$17.0 million recorded in 2022.
• Year-over-year, Net Income towards Common Stockholders plunged 2759.97% in 2022 and soared 174.26% in 2024.
• CareDx's Net Income towards Common Stockholders stood at -$18.3 million in 2022, then slumped by 544.32% to -$118.1 million in 2023, then soared by 174.26% to $87.7 million in 2024, then tumbled by 104.68% to -$4.1 million in 2025, then surged by 168.38% to $2.8 million in 2026.
• Business Quant data shows CDNA's Net Income towards Common Stockholders at $2.8 million in Q1 2026, -$4.1 million in Q4 2025, and $1.7 million in Q3 2025.